These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36333962)

  • 1. Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation.
    Xie L; Li J; Wang L; Dai Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1864. PubMed ID: 36333962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional MnO
    Yang G; Ji J; Liu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1720. PubMed ID: 33908171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Metal-Phenolic Networks for Cancer Theranostics.
    Zhang Z; Xie L; Ju Y; Dai Y
    Small; 2021 Oct; 17(43):e2100314. PubMed ID: 34018690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling tumor microenvironment with nanomedicines.
    Martin JD; Miyazaki T; Cabral H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Microenvironment-Enabled Nanotherapy.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design strategies for enhancing antitumor efficacy through tumor microenvironment exploitation using albumin-based nanosystems: A review.
    Zhang C; Yang K; Yang G
    Int J Biol Macromol; 2024 Feb; 258(Pt 2):129070. PubMed ID: 38163506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.
    Xu Q; Lan X; Lin H; Xi Q; Wang M; Quan X; Yao G; Yu Z; Wang Y; Yu M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1842. PubMed ID: 35989568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-phenolic networks for cancer theranostics.
    Liu P; Shi X; Zhong S; Peng Y; Qi Y; Ding J; Zhou W
    Biomater Sci; 2021 Apr; 9(8):2825-2849. PubMed ID: 33688863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.
    Peng S; Xiao F; Chen M; Gao H
    Adv Sci (Weinh); 2022 Jan; 9(1):e2103836. PubMed ID: 34796689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three Strategies in Engineering Nanomedicines for Tumor Microenvironment-Enabled Phototherapy.
    He S; Jia X; Feng S; Hu J
    Small; 2023 Sep; 19(37):e2300078. PubMed ID: 37226364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment.
    Zhang N; Zhou J; Li S; Cai W; Ru B; Hu J; Liu W; Liu X; Tong X; Zheng X
    Mol Pharm; 2024 Feb; 21(2):410-426. PubMed ID: 38170627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface-nanoengineering for cancer targeting immunoregulation and precise immunotherapy.
    Wang Y; Huang G; Hou Q; Pan H; Cai L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1875. PubMed ID: 36567668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective.
    Liu J; Bai Y; Li Y; Li X; Luo K
    EBioMedicine; 2024 Sep; 107():105301. PubMed ID: 39178747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved cancer immunotherapy strategies by nanomedicine.
    Guo S; Feng J; Li Z; Yang S; Qiu X; Xu Y; Shen Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1873. PubMed ID: 36576112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer nanomedicines harnessing tumor microenvironmental components.
    Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
    Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
    Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
    Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
    Sandbhor P; Palkar P; Bhat S; John G; Goda JS
    Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.